Guthrie Health does not buy any products from the New England Compounding Center in Framingham, Mass., that is currently linked to the fungal meningitis outbreak.

According to a press release provided by Guthrie representative Carolyn Handrick, Guthrie Clinic, Guthrie Robert Packer Hospital, Guthrie Corning Hospital and Guthrie Troy Community Hospital do not use any products from New England Compounding Center including the injectable steroid identified as the source of the recent outbreak.

The CDC has identified an injectable steroid medication product from New England Compounding Center as the likely source of a fungal meningitis outbreak currently affecting five southeastern states. A common use of this drug is epidural steroid injections, a procedure used to treat back pain.

Guthrie Health is a community-based, not-for-profit health care system jointly formed by Guthrie Healthcare System (GHS) and Guthrie Clinic, also not-for-profit health care organizations. GHS provides inpatient, outpatient and home-based services through Corning Hospital, Troy Community Hospital, Robert Packer Hospital, and Guthrie Home Care and Guthrie Hospice. Guthrie Clinic provides primary and specialty physician services at 25 regional clinics. Guthrie Health provides care for 200,000 patients annually within its eleven-county area service area across the northern tier of Pennsylvania and the southern tier of New York.

Submitted by Guthrie Health.